[HTML][HTML] Emerging strategies to target RAS signaling in human cancer therapy
K Chen, Y Zhang, L Qian, P Wang - Journal of hematology & oncology, 2021 - Springer
Abstract RAS mutations (HRAS, NRAS, and KRAS) are among the most common
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
Emerging strategies to target RAS signaling in human cancer therapy
K Chen, Y Zhang, L Qian, P Wang - Journal of Hematology & Oncology, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p>< jats: italic> RAS</jats: italic> mutations (< jats:
italic> HRAS</jats: italic>,< jats: italic> NRAS</jats: italic>, and< jats: italic> KRAS</jats …
italic> HRAS</jats: italic>,< jats: italic> NRAS</jats: italic>, and< jats: italic> KRAS</jats …
[HTML][HTML] Emerging strategies to target RAS signaling in human cancer therapy
K Chen, Y Zhang, L Qian… - … of Hematology & …, 2021 - jhoonline.biomedcentral.com
RAS mutations (HRAS, NRAS, and KRAS) are among the most common oncogenes, and
around 19% of patients with cancer harbor RAS mutations. Cells harboring RAS mutations …
around 19% of patients with cancer harbor RAS mutations. Cells harboring RAS mutations …
Emerging strategies to target RAS signaling in human cancer therapy
K Chen, Y Zhang, L Qian… - Journal of Hematology & …, 2021 - search.proquest.com
Abstract RAS mutations (HRAS, NRAS, and KRAS) are among the most common
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
Emerging strategies to target RAS signaling in human cancer therapy
K Chen, Y Zhang, L Qian… - Journal of hematology …, 2021 - pubmed.ncbi.nlm.nih.gov
RAS mutations (HRAS, NRAS, and KRAS) are among the most common oncogenes, and
around 19% of patients with cancer harbor RAS mutations. Cells harboring RAS mutations …
around 19% of patients with cancer harbor RAS mutations. Cells harboring RAS mutations …
Emerging strategies to target RAS signaling in human cancer therapy.
K Chen, Y Zhang, L Qian, P Wang - Journal of Hematology & Oncology, 2021 - go.gale.com
RAS mutations (HRAS, NRAS, and KRAS) are among the most common oncogenes, and
around 19% of patients with cancer harbor RAS mutations. Cells harboring RAS mutations …
around 19% of patients with cancer harbor RAS mutations. Cells harboring RAS mutations …
Emerging strategies to target RAS signaling in human cancer therapy.
K Chen, Y Zhang, L Qian, P Wang - Journal of Hematology & …, 2021 - europepmc.org
Abstract RAS mutations (HRAS, NRAS, and KRAS) are among the most common
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
Emerging strategies to target RAS signaling in human cancer therapy.
K Chen, Y Zhang, L Qian… - Journal of Hematology & …, 2021 - search.ebscohost.com
Abstract RAS mutations (HRAS, NRAS, and KRAS) are among the most common
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
[HTML][HTML] Emerging strategies to target RAS signaling in human cancer therapy
K Chen, Y Zhang, L Qian, P Wang - Journal of Hematology & …, 2021 - ncbi.nlm.nih.gov
Abstract RAS mutations (HRAS, NRAS, and KRAS) are among the most common
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
[PDF][PDF] Emerging strategies to target RAS signaling in human cancer therapy
K Chen, Y Zhang, L Qian, P Wang - 2021 - jhoonline.biomedcentral.com
Abstract RAS mutations (HRAS, NRAS, and KRAS) are among the most common
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …
oncogenes, and around 19% of patients with cancer harbor RAS mutations. Cells harboring …